US/UK/Canada

Share

Contacts

  • Dag Bergheim Pettersen

    CEO


    Hulda Mellgrens gata 5 421 32 Västra Frölunda Sweden
    +46 (0) 31 771 71 50
    http://www.zinzino.com
    • Pick a time period -
    Tags ( Active)

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2022

    Zinzino group revenue increased with a total of 13%, compared with the previous year. The revenue in November for Zinzino's sales markets increased by 13% and amounted to SEK 159.6 (140.8) million. Faun Pharma's external sales increased by 5% and amounted to SEK 5.8 (5.5) million. Overall, the Group increased revenues by 13% to SEK 165.4 (146.3) million compared with the previous year. Accumulated revenue for January – November 2022 increased by 7% to SEK 1312.6 (1222.4) million. Revenues were distributed as follows: Regions, mSEK 22-Nov 21-Nov Change YTD 2022 YTD

    ZINZINO AB (PUBL): INTERIM REPORT FIRST QUARTER 2022

    MAINTAINED SALES LEVEL WITH SATISFACTORY PROFITABILITYRevenues during the first quarter of 2022 amounted to SEK 334.4 (333.4) million, which corresponded to 0.3% (38.0%) growth compared with the corresponding period last year. The EBITDA result amounted to SEK 25.8 (37.3) million and the EBITDA margin to 7.7% (11.2%). It showed that the company managed to maintain sales levels combined with good profitability despite the impact of external conditions with increased costs related to raw materials and transport, covid outbreaks among distributors and effects of the war between Russia and

    ZINZINO AB (PUBL): YEAR-END REPORT 2021

    20% SALES GROWTH AND RECORD RESULTS 2021 – SIGNIFICANTLY INCREASED DIVIDEND AT SEK 2 / SHARE PROPOSEDFor the full year 2021 the total revenues amounted to SEK 1,370.6 (1,138.6) million, which corresponded to 20% growth compared with the previous year. EBITDA increased to SEK 137.6 (108.5) million and the EBITDA margin to 10.0% (9.5%). The margin improvement for the year was mainly the result of increased profitability at the gross level in combination with economies of scale because of improved efficiency in IT systems and in the organisation as a whole. The good profitability over the

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2022

    Zinzino group revenue increased with a total of 2 %, compared with the previous year.The revenue in January for Zinzino's sales markets remained at the same level as last year and amounted to SEK 102.2 (101.7) million. Faun Pharma's external sales increased by 26% and amounted to SEK 6.7 (5.3) million. Overall, the Group increased revenues by 2% to SEK 108.9 (107.0) million compared with the previous year. Revenues were distributed as follows: Regions,MSEK 22-jan 21-jan ChangeThe Nordics 26.0 30.6 -15%Central Europe 18.4 18.5 -1%East

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2021

    Strong sales growth during 2021; Zinzino group revenue increased with a total of 15% in Q4 and 20% for the full year 2021, compared with the previous year.The revenue in December for Zinzino's sales markets increased by 6% to SEK 135.2 (127.3) million due to solid growth in several regions. Faun Pharma's external sales decreased by 38% and amounted to SEK 4.0 (6.5) million. Overall, the Group increased revenues by 4% to SEK 139.2 (133.8) million compared with the previous year. The fourth quarter of 2021 became a solid quarter; the Zinzino based revenue in October – December increased by

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2021

    Strong sales growth during November; Zinzino group revenue increased with a total of 48%, compared with the previous year.The revenue in November for Zinzino’s sales markets increased by 49% to SEK 140.7 (94.6) million due to strong growth in several regions. Faun Pharma’s external sales increased by 28% and amounted to SEK 5.5 (4.3) million. Overall, the Group increased revenues by 48% to SEK 146.2 (98.9) million compared with the previous year. Accumulated revenue for January – November 2021 increased by 22% to SEK 1221.5 (1004.8) million. Revenues were distributed as follows:

    ZINZINO AB (PUBL): INTERIM REPORT THIRD QUARTER 2021

    FURTHER INCREASED PROFIT FORECAST AFTER ANOTHER STRONG QUARTERThe third quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability. Total revenues in the Group increased by 11% and amounted to SEK 313.6 (281.8) million. EBITDA result amounted to SEK 40.4 (28.8) million for the quarter and the EBITDA margin amounted to 12.9% (10.2%). During the quarter, Taiwan achieved full market status. In addition, after the end of the quarter a new test concept for Vitamin D levels was launched with the introduction of the new products Vitamin D Test and

    ZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022

    In accordance with decision by the Annual General Meeting, Zinzino AB’s Nomination Committee shall consist of three members. The members are selected by the two largest shareholders in the company that wish to participate in the committee. In addition, the Chairman of the Board is to be appointed to the Nomination Committee. In accordance with the above principles, the Nomination Committee consists of the following three members: • Hans Jacobsson, chairman of the board of Zinzino AB • Magnus Götenfelt, representing Saele Invest AS och the Saele family • Cecilia Halldner,

    ZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion

    Zinzino is very proud to announce the launch of its business in South Africa on November 9, 2021, as a strategic part of the company’s global expansion strategy.After several years of preparing the launch of the South African market and having carried out multiple country establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market. Profitable growth is an important business strategy for the e-commerce-based health tech company Zinzino. During 2020 the company sales target was

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2021

    Zinzino group revenue decreased with a total of 3%, compared with the previous year.The revenue in October for Zinzino's sales markets stayed on the same level as last year and amounted to SEK 101.2 (100.8) million. Faun Pharma's external sales decreased by 46% and amounted to SEK 3.7 (6.9) million. Overall, the Group decreased revenues by 3% to SEK 104.9 (107.7) million compared with the previous year. Accumulated revenue for January – October 2021 increased by 19% to SEK 1074.3 (905.9) million. Revenues were distributed as follows: Regions,MSEK 21-okt 20-okt Change YTD

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2021

    Solid sales growth during Q3; Zinzino group revenue increased with a total of 11%, compared with the previous year.The revenue in September for Zinzino's sales markets increased by 10% to SEK 111.6 (101.7) million due to solid growth in several regions. Faun Pharma's external sales increased by 13% and amounted to SEK 6.2 (5.5) million. Overall, the Group increased revenues by 10% to SEK 117.8 (107.2) million compared with the previous year. The third quarter of 2021 became a solid quarter; the Zinzino based revenue in July – September increased by 11% to SEK 298.8 (269.0) million

    ZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion

    The global, direct selling company within test-based, scientifically proven nutrition is very proud to announce the launch of its business in Taiwan on September 9, 2021 as a strategic part of the company’s mission towards global expansion. After several years of preparing the launch of the Taiwan market and having carried out multiple market establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market. Profitable growth is an important business strategy for the e-commerce-based

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT AUGUST 2021

    Strong sales growth during August; Zinzino group revenue increased with a total of 14%, compared with the previous year.The revenue in August for Zinzino's sales markets increased by 13% to SEK 92.2 (81.9) million due to strong growth in several regions. Faun Pharma's external sales increased by 37% and amounted to SEK 4.8 (3.5) million. Overall, the Group increased revenues by 14% to SEK 97.0 (85.4) million compared with the previous year. Accumulated revenue for January – August 2021 increased by 23% to SEK 851.3 (690.9) million. Revenues were distributed as follows: Regions,MSEK

    ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2021

    INCREASED PROFIT FORECAST AFTER ANOTHER STRONG QUARTERThe second quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability. Total revenues in the Group increased by 18% and amounted to SEK 322.4 (274.3) million. EBITDA result amounted to SEK 33.4 (16.0) million for the quarter and the EBITDA margin amounted to 10.4% (5.8%). The margin improvement is achieved through economies of scale due to improved efficiency in IT systems, logistics and within the organization. During the quarter, sales started in India, and Malaysia achieved full market

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JULY 2021

    Strong sales growth during July; Zinzino group revenue increased with a total of 11%, compared with the previous year.The revenue in July for Zinzino's sales markets increased by 13% to SEK 96.3 (85.3) million due to strong growth in several regions. Faun Pharma's external sales decreased by 23% and amounted to SEK 3.0 (3.9) million. Overall, the Group increased revenues by 11% to SEK 99.3 (89.2) million compared with the previous year. Accumulated revenue for January – July 2021 increased by 25% to SEK 755.2 (605.5) million. Revenues were distributed as follows: Regions,MSEK

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q2 2021

    Strong sales growth during Q2: Zinzino group revenue increased with a total of 17%, compared with the previous year.The revenue in June for Zinzino's sales markets increased by 8% to SEK 102.4 (94.6) million due to solid growth in several regions. Faun Pharma's external sales decreased by 28% and amounted to SEK 3.8 (5.3) million due to high internal production during the month. Overall, the Group increased revenues by 6% to SEK 106.2 (99.9) million compared with the previous year. The second quarter of 2021 became a strong quarter; the Zinzino based revenue in April - June increased 18%

    ANNUAL REPORT ENGLISH 2020 ZINZINO AB (PUBL)

    Zinzino (publ.) announces that the Annual Report for 2020 is now available for download in English at the company’s website, www.zinzino.com.  For more information: Fredrik Nielsen, CFO Zinzino + 46 (0) 707 900 174, zinzino.com Pictures for publication free of charge: Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollblom@zinzino.com Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT MAY 2021

    Strong sales growth during May; Zinzino group revenue increased with a total of 26%, compared with the previous year.The revenue in May for Zinzino’s sales markets increased by 31% to SEK 104.3 (79.4) million due to strong growth in several regions. Faun Pharma's external sales decreased by 35% and amounted to SEK 4.5 (6.9) million. Overall, the Group increased revenues by 26% to SEK 108.8 (86.3) million compared with the previous year. Accumulated revenue for January – May 2021 increased by 32% to SEK 548.7 (416.5) million. Revenues were distributed as follows: Regions, MSEK

    ZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion

    Zinzino is very proud to announce the launch of its business in Malaysia on June 3, 2021 as a strategic part of the company’s global expansion strategy. After several years of preparing the launch of the Malaysian market and having carried out multiple country establishment processes in recent years, Zinzino has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market. Profitable growth is an important business strategy for the e-commerce-based health tech company Zinzino. During 2020 the company sales target was exceeded

    ANNOUNCEMENT FROM THE ANNUAL GENERAL MEETING

    Zinzino AB (publ.) held its Annual General Meeting today, May 20, where it was mainly decided: · to adopt the income statement and balance sheet, and the consolidated income statement and consolidated balance sheet, · to distribute a dividend of SEK 1.25 per share for the financial year 2020 and to bring the remaining part of the retained earnings forward, · to grant discharge from liability to the Board members and the CEO, · to elect Hans Jacobsson as Chairman of the Board and Staffan Hillberg, Pierre Mårtensson, Ingela Nordenhav and Anna Frick as Board members, · that a

    ZINZINO AB (PUBL): INTERIM REPORT FIRST QUARTER 2021

    MAINTAINED STRONG SALES GROWTH WITH RECORD PROFITABILITYThe first quarter of 2021 was yet another quarter in which good sales growth was combined with high profitability.Total revenues in the Group increased by 38% and amounted to SEK 333.4 (242.1) million, after sales growth in all regions except the Nordics. Strongest growth continued to be found among the other European regions. Asia and North America also increased significantly during the quarter. Profitability was also very good, and the EBITDA result amounted to SEK 37.3 (26.3) million for the quarter. The EBITDA margin thus

    ZINZINO AB (PUBL): PRELIMINARY SALES REPORT APRIL 2021

    Strong sales growth during April; Zinzino group revenue increased with a total of 21%, compared with the previous year.The revenue in April for Zinzino's sales markets increased by 17% to SEK 98.7 (84.2) million due to strong growth in several regions. Faun Pharma's external sales increased by 97% and amounted to SEK 7.5 (3.8) million. Overall, the Group increased revenues by 21% to SEK 106.2 (88.0) million compared with the previous year. Accumulated revenue for January – April 2021 increased by 33% SEK 439.7 (330.2) million. Revenues were distributed as follows: Regions,MSEK

    NOTICE OF THE ANNUAL GENERAL MEETING OF ZINZINO AB (publ.)

    The shareholders of Zinzino AB (publ), org. no. 556733-1045 (the “Company”) are hereby invited to participate in the Annual General Meeting on Thursday, 20 May 2021.2021 ANNUAL GENERAL MEETING FORMATIn light of the extraordinary situation society finds itself in due to coronavirus, the format of the 2021 Annual General Meeting of Zinzino AB will be adapted accordingly. Taking into account the health of both the shareholders and the company representatives as well as ongoing efforts to limit the spread of infection, the Annual General Meeting will be held without the possibility of

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media